Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 413 JPY -1.21%
Market Cap: 7T JPY

P/E
Price to Earnings

33.6
Current
28.1
Median
20.8
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
33.6
=
Market Cap
7T JPY
/
Net Income
208.1B JPY
Earnings Growth PEG
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
Average P/E: 28.6
33.6
23%
1.5
US
Eli Lilly and Co
NYSE:LLY
73.6
49%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
28
26%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
20.5
19%
1.1
CH
Roche Holding AG
SIX:ROG
20.2
16%
1.3
UK
AstraZeneca PLC
LSE:AZN
31.8
36%
0.9
CH
Novartis AG
SIX:NOVN
18.8
16%
1.2
US
Merck & Co Inc
NYSE:MRK
13.2
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -57.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.8
29%
0.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
52.5
2-Years Forward
P/E
32.2
3-Years Forward
P/E
26.2